Comparative effects of dexamethasone and L-canavanine in experimental septic shock

European Journal of Pharmacology

Volumn 475, Issue 1-3, 2003, Pages 61-67

  Mansart, Arnaud ^a   Bollaert, Pierre Edouard ^b   Levy, Bruno ^b   Nicolas, Marie Bénédicte ^b   Mallié, Jean Pierre ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Hemodynamic; Nitric oxide (NO); Sepsis; Steroid; Vasopressor

Indexed keywords

CANAVANINE; DEXAMETHASONE; GLUCOCORTICOID; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA FLOW; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RODENT; SEPSIS; SEPTIC SHOCK; STEROID THERAPY; SURVIVAL;

EID: 0042883678     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02035-1     Document Type: Article

References (46)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:2001;1472-1474.
2. Annane D., Sebille V., Charpentier C., Bollaert P.E., Francois B., Korach J.M., Capellier G., Cohen Y., Azoulay E., Troche G., Chaumet-Riffaut P., Bellissant E. The effect of a seven-day treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 288:2002;862-871.
3. Aranow J., Zhuang J., Wang H., Larkin V., Smith M., Fink M.P. A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis. Comparison with two nonselective strategies. Shock. 5:1996;116-121.
4. Bellissant E., Annane D. Effect of hydrocortisone on phenylephrine - mean arterial pressure dose-response relationship in septic shock. Clin. Pharmacol. Ther. 68:2000;293-303.
5. Bollaert P.E., Charpentier C., Levy B., Debouverie M., Audibert G., Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit. Care Med. 26:1998;645-650.
6. Bone R.C., Fisher C.J., Clemmer T.P., Slotman G.J., Metz C.A., Balk R.A. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 317:1987;653-658.
7. Brady A.J.B., Poole-Wilson P.A., Harding S.E., Warren J.B. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxaemia. Am. J. Physiol. 263:1992;H1963-H1966.
8. Briegel J., Forst H., Haller M., Schelling G., Kilger E., Kuprat G., Hemmer B., Hummel T., Lenhart A., Heyduck M., Stoll C., Peter K. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomised, double-blind single-center study. Crit. Care Med. 27:1999;723-732.
9. Brun-Buisson C., Doyon F., Carlet J., Dellamonica P., Gouin F., Lepoutre A., Mercier J.C., Offenstadt G., Regnier B. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA. 274:1995;968-974.
10. Fishman D., Liaudet L., Lazor R., Feihl F., Perret C. L-Canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotemic rats. Crit. Care Med. 25:1997;469-475.
11. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.C., Tannenbaum F.R. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
12. Grover R., Lopez A., Lorente J., Steingrub J., Bakker J., Wilatts S., McLuckie A., Takala J. Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock (abstract). Crit. Care Med. 27(Suppl. 1):1999;A33.
13. G-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Crit. Care Med. 27:1999;913-922.
14. Hollenberg S.M., Broussard M., Osman J., Parrillo J.E. Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ. Res. 86:2000;774-778.
15. Jones S.B., Romano F.D. Plasma catecholamines in the conscious rat during endotoxicosis. Circ. Shock. 14:1984;189-201.
16. Keh D., Boehnke T., Weber-Cartens S., Schulz C., Ahlers O., Bercker S., Volk H.D., Doecke W.D., Falke K.J., Gerlach H. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am. J. Respir. Crit. Care Med. 167:2003;512-520.
17. Kelm M., Feelisch M., Grube R., Motz W., Strauer B.E. Metabolism of endothelium-derived nitric oxide in human blood. Moncada S., Marletta M.A., Hibbs J.B., Higgs E.A. The Biology of Nitric Oxide. 1992;453-463 Portland Press Proceedings, London. Part 1.
18. Knowles R.G., Merrett M., Salter M., Moncada S. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem. J. 270:1990;833-836.
19. Laubach V.E., Shesely E.G., Smithies O., Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. U. S. A. 92:1995;10688-10692.
20. Liaudet L., Feihl F., Rosselet A., Markert M., Perret C. Beneficial effects of L-canavanine, a selective inhibitor of inductible nitric oxide synthase, during rodent endotoxemia. Clin. Sci. 90:1996;369-377.
21. Liu A.Y., Greengard P. Regulation by steroid hormones of phosphorylation of specific protein common to several target organs. Proc. Natl. Acad. Sci. U. S. A. 73:1976;568-572.
22. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N., Chen H., Mudgett J.S. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650.
23. Mansart A., Bollaert P.E., Seguin C., Levy B., Longrois D., Mallié J.P. Hemodynamic effects of early versus late glucocorticoid administration in experimental septic shock. Shock. 19:2003;38-44.
24. Marumo T., Schini-Kerth V.B., Brandes R.P., Busse R. Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells. Hypertension. 32:1998;1083-1088.
25. Parrillo J.E. Cardiovascular pattern during septic shock. Ann. Intern. Med. 113:1990;227-231.
26. Petros A., Lamb G., Leone A., Moncada S., Bennett D., Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28:1994;34-39.
27. Piper R.D., Cook D.J., Bone R.C., Sibbald W.J. Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis. Crit. Care Med. 24:1996;2059-2070.
28. Radomski M.W., Palmer M.R.J., Moncada S. Glucocorticoids inhibit the expression of an inducible but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 87:1990;10043-10047.
29. Silverman H.J., Penaranda R., Orens J.B., Lee N.H. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit. Care Med. 21:1993;31-39.
30. Simmons W.W., Ungureanu-Longrois D., Smith G.K., Smith T.W., Kelly R.A. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J. Biol. Chem. 271:1996;23928-23937.
31. Statman R., Cheng W., Cunningham N., Henderson J.L., Damiani P., Siconolfi A., Rogers D., Horovitz J.H. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J. Surg. Res. 57:1994;93-98.
32. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz. 3:1995;2-32.
33. Szabo C., Southan G.J., Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methyl-isothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 91:1994;12472-12476.
34. Tang C., Liu M.S. Initial externalization followed by internalization of beta-adrenergic receptors in rat heart during sepsis. Am. J. Physiol. 270:1996;R254-R263.
35. Tang C., Yang J., Wu L.L., Dong L.W., Liu M.S. Phosphorylation of b-adrenergic receptor leads to its redistribution in rat heart during sepsis. Am. J. Physiol. 274:1998;R1078-R1086.
36. Tavernier B., Li J.M., El-Omar M.M., Lanone S., Yang Z.K., Trayer I.P., Mebazaa A., Shah A.M. Cardiac contractile impairment associated with increased phosphorylation of troponin I in endotoxemic rats. FASEB J. 15:2001;294-296.
37. Tavernier B., Mebazaa A., Mateo P., Sys S., Ventura-Clapier R., Veksler V. Phosphorylation-dependent alteration in myofilament Ca2+ sensitivity but normal mitochondrial function in septic heart. Am. J. Respir. Crit. Care Med. 163:2001;362-367.
38. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N. Engl. J. Med. 317:1987;659-665.
39. Thiemermann C., Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182:1990;591-595.
40. Ullrich R., Scherre-Crosbie M., Bloch K.D., Ichinose F., Nakajima H., Picard M.H., Zapol W.M., Quezado Z.M. Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation. 102:2000;1440-1446.
41. Umans J.G., Samsel R.W. L-Canavanine selectively augments contraction in aortas from endotoxemic rats. Eur. J. Pharmacol. 210:1992;343-346.
42. Vatner D.E., Vatner S.F., Nejima J., Uemura N., Susanni E.E., Hintze T.H., Homcy C.J. Chronic norepinephrine elicits desensitization by uncoupling the b-receptor. J. Clin. Invest. 84:1989;1741-1748.
43. Wakabayashi I., Hatake K., Kakishita E., Hishida S., Nagai K. Desensitization of alpha 1 adrenergic receptor mediated smooth muscle contraction in aorta from endotoxic rats. Life Sci. 45:1989;509-515.
44. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
45. Wichterman K.A., Baue A.E., Chaudry I.H. Sepsis and septic shock - a review of laboratory models and a proposal. J. Surg. Res. 29:1980;189-201.
46. Wright C.E., Rees D.D., Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26:1992;48-57.